NICE Guidelines NG 163 and NG165

When NICE guidelines are replaced, the originals seem to disappear without trace.

COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community (NG163) was published on 3rd April 2020, and gave the now notorious advice on use of Morphine and Midazolam to relieve distress in patients with Covid-19. Both are respiratory depressants, so in combination the last thing you would want if you were trying to fight off pneumonia. Palliative care consultants spoke out about the risk of these drugs in use by inexperienced staff and in facilities without resuscitation facilities. In palliative care, they are used for pain relief in patients who definitely have a terminal diagnosis such as advanced cancer, but the skill lies in titrating the dose to give the minimum required for pain relief yet maintaining lucidity.

COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community (NG165) was published on the same date and included the following statements. “As COVID-19 becomes more prevalent in the community, patients presenting with pneumonia symptoms are more likely to have a COVID-19 viral pneumonia than a community-acquired bacterial pneumonia. As COVID-19 pneumonia is caused by a virus, antibiotics are ineffective.”

Both these guidelines were replaced by NG191 in March 2021 and are no longer available on the NICE website.